We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,906

House of Representatives v. Burwell: Another Blow to Obamacare
  • Foley & Lardner LLP
  • USA
  • May 16 2016

Federal Judge Rosemary Collyer's May 12, 2016 ruling in House of Representatives v. Burwell, found that the Obama administration (the


Amgen And Sandoz Do The Biosimilar Patent Dance Over Neulasta
  • Foley & Lardner LLP
  • USA
  • May 17 2016

Amgen Inc. has filed a complaint under the Biologics Price Competition and Innovation Act (BPCIA), asserting that a biosimilar application filed by


DOJ Files IPR Petitions Against Discovery Patents
  • Foley & Lardner LLP
  • USA
  • May 17 2016

The U.S. Department of Justice (DOJ) filed six petitions for inter partes review (IPR) of three patents assigned to Discovery Patents, LLC. The


It’s a Jungle Out There: A Reexamination Certificate Containing Amended Claims May Be Insufficient to Vacate a Prior Judgment of Invalidity
  • Foley & Lardner LLP
  • USA
  • May 16 2016

In a case with a unique procedural history the Federal Circuit addressed whether claims amended during an ex parte reexamination proceeding required


Seventh Circuit Sets Relatively Low Threshold to Establish Standing in Data Breach Class Actions
  • Foley & Lardner LLP
  • USA
  • May 18 2016

With the proliferation of storage of personal data and the increase in hacking efforts and phishing scams, Wisconsin courts are likely to see more


New USPTO Guidance On Patent Eligibility Of Diagnostic Methods
  • Foley & Lardner LLP
  • USA
  • May 9 2016

The patent eligibility examples published by the USPTO on May 5, 2016 include two new examples relating to diagnostic methods and two new examples


EU-U.S. Privacy Shield Agreement Released
  • Foley & Lardner LLP
  • European Union, USA
  • March 1 2016

The European Commission and the U.S. Department of Commerce released draft documents that will constitute the new Privacy Shield to permit


Orchestra Left Without A Chair When The Music Stops: Another Independent Contractor Misclassification
  • Foley & Lardner LLP
  • USA
  • April 25 2016

How independent are musicians who play and perform with others? Do they have more artistic control on their own, or do they only become truly great


Remicade Biosimilar Closer To Approval, But Patent Dance Goes On
  • Foley & Lardner LLP
  • USA
  • February 11 2016

Celltrion’s biosimilar version of Janssen’s Remicade (infliximab) product cleared a significant regulatory hurdle on February 9, 2016, when the Food


Brady's Benching Gives Lesson in Court Review of Arbitration Decisions
  • Foley & Lardner LLP
  • USA
  • May 2 2016

Earlier this week, Bills and Jets fans (and at least one Packer fan) rejoiced as the Second Circuit Court of Appeals reinstated the NFL’s four-game